(Q82037910)
Statements
Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting (English)
William J Valentine
Andrew J Palmer
Morten Lammert
Lars Nicklasson
Volker Foos
Stéphane Roze
1 December 2005